Research square · 2026
A Transgenic Syrian Hamster Model for New World Hemorrhagic Fever Mammarenavirus Infection.
СтатьяПрепринтНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wasson Samantha R, Liu Yanan, Li Minghao, Bailey Kevin W, Westover Jonna B, Landinez-Aponte Julio, Van Wettere Arnaud, Siddharthan Venkatraman, Davies Christopher J, Daniels-Wells Tracy R, Li Rong, Penichet Manuel L, Wang Zhongde, Gowen Brian B
Аннотация
Mammarenaviruses are endemic in rodent populations worldwide, and their zoonotic transmission can lead to a severe, life-threatening hemorrhagic fever (HF) syndrome. In the Americas, five New World mammarenaviruses (NWMs) are known to cause HF. In the absence of FDA-licensed vaccines or antiviral therapies, these viruses pose a significant public health risk and a threat to national security. Research into NWM pathogenesis and the development of effective countermeasures is severely limited by the lack of small-animal models that faithfully reproduce human disease. The pathogenic NWMs use human transferrin receptor 1 (hTfR1) as the receptor for cellular entry. Here, we describe the development of an hTfR1 knock-in (KI) golden Syrian hamster line and its susceptibility to Junín virus (JUNV) infection. This transgenic hamster infection model supports TfR1-mediated entry as an essential step in JUNV pathogenesis and provides a novel small-animal model to advance the development of promising host receptor-directed therapies and direct-acting antivirals to improve outcomes in patients with severe disease caused by pathogenic NWMs.